Literature DB >> 26279692

Evaluation of Selective Arterial Embolization Effect by Chitosan Micro-Hydrogels in Hindlimb Sarcoma Rodent Models Using Various Imaging Modalities.

Tai Kyoung Lee1, JeongIl Kwon2, Kyung Sook Na1, Hwan-Seok Jeong1, Hyosook Hwang1, Phil-Sun Oh1, Dong Hyun Kim2, Kyu Yun Jang3, Seok Tae Lim1, Myung-Hee Sohn1, Hwan-Jeong Jeong4.   

Abstract

PURPOSE: Embolization is mainly used to reduce the size of locally advanced tumors. In this study, selective arterial catheterization with chitosan micro-hydrogels (CMH) into the femoral artery was performed and the therapeutic effect was validated using different imaging methods.
METHODS: Male SD rats (n = 18, 6 weeks old) were randomly assigned into three groups: Group 1 as control, Group 2 without any ligation of distal femoral artery, and Group 3 with temporary ligation of the distal femoral artery. RR1022 sarcoma cell lines were inoculated into thigh muscle. After 1 week, CMH was injected into the proximal femoral artery. Different imaging modalities were performed during a 3-week follow-up.
RESULTS: The tumor size was significantly (P < 0.001) decreased in both Group 2 and Group 3 (P < 0.001) after selective arterial embolization therapy. (18)F-FDG-PET/CT revealed decreased intensity of (18)F-FDG uptake in tumors. The accumulation status of (125)I-CMH near the tumor was verified by gamma camera.
CONCLUSIONS: Appropriate selective arterial embolization therapy with CMH was.

Entities:  

Keywords:  Chitosan micro-hydrogel; Gamma camera; Molecular imaging; Positron emission tomography (PET); RR1022; Rodent; Sarcoma; Selective arterial embolization; Ultrasonography

Year:  2015        PMID: 26279692      PMCID: PMC4532684          DOI: 10.1007/s13139-014-0316-y

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


  18 in total

1.  Superselective intra-arterial radiometabolic therapy with I-131 lipiodol in hepatocellular carcinoma.

Authors:  C L Maini; M G Scelsa; C Fiumara; A Tofani; R Sciuto; L Tipaldi; M D'Annibale; E Santoro
Journal:  Clin Nucl Med       Date:  1996-03       Impact factor: 7.794

2.  Feasibility and safety of vascular closure devices in an antegrade approach to either the common femoral artery or the superficial femoral artery.

Authors:  Andreas Gutzeit; Bram van Schie; Eric Schoch; Klaus Hergan; Nicole Graf; Christoph A Binkert
Journal:  Cardiovasc Intervent Radiol       Date:  2012-08-03       Impact factor: 2.740

3.  Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C).

Authors:  Alice Dewdney; David Cunningham; Josep Tabernero; Jaume Capdevila; Bengt Glimelius; Andres Cervantes; Diana Tait; Gina Brown; Andrew Wotherspoon; David Gonzalez de Castro; Yu Jo Chua; Rachel Wong; Yolanda Barbachano; Jacqueline Oates; Ian Chau
Journal:  J Clin Oncol       Date:  2012-04-02       Impact factor: 44.544

Review 4.  Transarterial (chemo)embolization for curative resection of hepatocellular carcinoma: a systematic review and meta-analyses.

Authors:  Xiang Cheng; Ping Sun; Qing-Gang Hu; Zi-Fang Song; Jun Xiong; Qi-Chang Zheng
Journal:  J Cancer Res Clin Oncol       Date:  2014-04-22       Impact factor: 4.553

5.  Accuracy of hepatocellular carcinoma detection on multidetector CT in a transplant liver population with explant liver correlation.

Authors:  H C Addley; N Griffin; A S Shaw; L Mannelli; R A Parker; S Aitken; H Wood; S Davies; G J Alexander; D J Lomas
Journal:  Clin Radiol       Date:  2011-02-04       Impact factor: 2.350

Review 6.  Controversies in the role of preoperative embolization in meningioma management.

Authors:  Amit Singla; Eric M Deshaies; Vlad Melnyk; Gentian Toshkezi; Amar Swarnkar; Hoon Choi; Lawrence S Chin
Journal:  Neurosurg Focus       Date:  2013-12       Impact factor: 4.047

7.  Neoadjuvant therapy and breast cancer surgery: a closer look at postoperative complications.

Authors:  Erin M Garvey; Richard J Gray; Nabil Wasif; William J Casey; Alanna M Rebecca; Peter Kreymerman; Deborah Bash; Barbara A Pockaj
Journal:  Am J Surg       Date:  2013-10-01       Impact factor: 2.565

8.  Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis.

Authors:  Francis Y Yao; Robert K Kerlan; Ryutaro Hirose; Timothy J Davern; Nathan M Bass; Sandy Feng; Marion Peters; Norah Terrault; Chris E Freise; Nancy L Ascher; John P Roberts
Journal:  Hepatology       Date:  2008-09       Impact factor: 17.425

9.  AS30D model of hepatocellular carcinoma: tumorigenicity and preliminary characterization by imaging, histopathology, and immunohistochemistry.

Authors:  Scott M Thompson; Matthew R Callstrom; Bruce Knudsen; Jill L Anderson; Kim A Butters; Joseph P Grande; Lewis R Roberts; David A Woodrum
Journal:  Cardiovasc Intervent Radiol       Date:  2012-08-25       Impact factor: 2.740

10.  Liver cancer imaging: role of CT, MRI, US and PET.

Authors:  Maria Raquel Oliva; Sanjay Saini
Journal:  Cancer Imaging       Date:  2004-04-02       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.